• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的下肢血运重建术后死亡率和主要截肢率的研究。

Population-based study of mortality and major amputation following lower limb revascularization.

机构信息

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK.

出版信息

Br J Surg. 2018 Aug;105(9):1145-1154. doi: 10.1002/bjs.10823. Epub 2018 Apr 25.

DOI:10.1002/bjs.10823
PMID:29691863
Abstract

BACKGROUND

The aim of this study was to estimate separate risks of major lower limb amputation and death following revascularization for peripheral artery disease (PAD) using competing risks analysis.

METHODS

Routinely collected data from Hospital Episode Statistics (HES) were used to identify patients who underwent endovascular or open lower limb revascularization for PAD in England from 2005 to 2015. The primary outcomes were major lower limb amputation and death within 5 years of revascularization. Cox proportional hazards and Fine-Gray competing risks regression were used to examine the competing risks of these outcomes.

RESULTS

Some 164 845 patients underwent their first lower limb revascularization for PAD during the study interval. Most were men (64·6 per cent) and the median age was 71 (i.q.r. 62-78) years. Following endovascular revascularization, the 5-year cumulative incidence of amputation was 4·2 per cent in patients with intermittent claudication and 18·0 per cent in those with a record of tissue loss. The corresponding rates were 10·8 and 25·3 per cent respectively after open revascularization, and 8·1 and 25·0 per cent after combined procedures. The 5-year cumulative incidence of death varied from 24·5 to 39·8 per cent, depending on procedure type. Competing risks methods consistently produced lower estimates than standard methods.

CONCLUSION

The 5-year risk of major amputation following lower limb revascularization for PAD appears lower than estimated previously. Patients undergoing revascularization for tissue loss and those who require an open procedure are at highest risk of limb loss.

摘要

背景

本研究旨在通过竞争风险分析估计外周动脉疾病(PAD)血管重建后主要下肢截肢和死亡的单独风险。

方法

使用来自医院病例统计数据(HES)的常规收集数据,确定 2005 年至 2015 年间在英格兰接受血管内或开放下肢血运重建术治疗 PAD 的患者。主要结局为血管重建后 5 年内主要下肢截肢和死亡。使用 Cox 比例风险和 Fine-Gray 竞争风险回归来检查这些结局的竞争风险。

结果

在研究期间,约有 164845 名患者接受了首次 PAD 下肢血运重建术。大多数患者为男性(64.6%),中位年龄为 71(IQR62-78)岁。血管内血管重建后,间歇性跛行患者 5 年累积截肢发生率为 4.2%,有组织损失记录的患者为 18.0%。开放血管重建后,相应的发生率分别为 10.8%和 25.3%,联合手术后分别为 8.1%和 25.0%。血管重建后 5 年的死亡率各不相同,取决于手术类型,范围为 24.5%至 39.8%。竞争风险方法产生的估计值始终低于标准方法。

结论

PAD 下肢血管重建后主要截肢的 5 年风险似乎低于之前的估计。因组织损失而行血运重建的患者和需要开放手术的患者有更高的肢体丧失风险。

相似文献

1
Population-based study of mortality and major amputation following lower limb revascularization.基于人群的下肢血运重建术后死亡率和主要截肢率的研究。
Br J Surg. 2018 Aug;105(9):1145-1154. doi: 10.1002/bjs.10823. Epub 2018 Apr 25.
2
Improving 1-Year Outcomes of Infrainguinal Limb Revascularization: Population-Based Cohort Study of 104 000 Patients in England.改善下肢血运重建 1 年的结果:英国 104000 例患者的基于人群的队列研究。
Circulation. 2018 May 1;137(18):1921-1933. doi: 10.1161/CIRCULATIONAHA.117.029834. Epub 2018 Jan 9.
3
Illness Trajectories After Revascularization in Patients With Peripheral Artery Disease: A Unified Approach to Understanding the Risk of Major Amputation and Death.外周动脉疾病患者血运重建后的疾病进程:理解主要截肢和死亡风险的统一方法。
Circulation. 2024 Jul 23;150(4):261-271. doi: 10.1161/CIRCULATIONAHA.123.067687. Epub 2024 Jul 22.
4
Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.糖尿病患者和非糖尿病患者下肢血管腔内血运重建后的主要肢体结局
J Endovasc Ther. 2017 Jun;24(3):376-382. doi: 10.1177/1526602817705135. Epub 2017 Apr 25.
5
High hemoglobin A associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.血红蛋白 A 水平高与外周动脉疾病患者血运重建后不良肢体事件增加相关。
J Vasc Surg. 2018 Jan;67(1):217-228.e1. doi: 10.1016/j.jvs.2017.06.101. Epub 2017 Aug 31.
6
Peripheral Artery Disease Leading to Major Amputation: Trends in Revascularization and Mortality Over 18 Years.外周动脉疾病导致的主要截肢:18 年来血管再通和死亡率的趋势。
Ann Vasc Surg. 2022 Jan;78:295-301. doi: 10.1016/j.avsg.2021.04.037. Epub 2021 Jun 25.
7
Outcomes of lower extremity revascularization among the hemodialysis-dependent.依赖血液透析患者的下肢血管重建术的治疗结果
J Vasc Surg. 2015 Nov;62(5):1183-91.e1. doi: 10.1016/j.jvs.2015.06.203. Epub 2015 Aug 5.
8
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.对于因膝下动脉疾病导致慢性肢体威胁性缺血的患者,采用旁路优先与血管内优先策略的临床结果。
J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244.
9
Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.下肢动脉疾病初次血运重建策略中旁路和血管内介入治疗的患者选择和围手术期结局。
J Vasc Surg. 2018 Jan;67(1):206-216.e2. doi: 10.1016/j.jvs.2017.05.132. Epub 2017 Aug 24.
10
Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.血管外科学会伤口、缺血和足部感染(WIfI)分类系统对首次下肢血运重建术后的预测能力。
J Vasc Surg. 2017 Mar;65(3):695-704. doi: 10.1016/j.jvs.2016.09.055. Epub 2017 Jan 7.

引用本文的文献

1
Non-Traumatic Lower-Limb Amputations: Outcome, Sex-Differences, Comorbidity Patterns and Temporal Trends from 2006 to 2022.非创伤性下肢截肢:2006年至2022年的结果、性别差异、合并症模式及时间趋势
J Clin Med. 2025 Jun 6;14(12):4030. doi: 10.3390/jcm14124030.
2
Impact of Timing of Minor Amputations After Revascularization on Patient Outcomes.血管再通术后小截肢时机对患者预后的影响。
Cureus. 2024 Nov 18;16(11):e73947. doi: 10.7759/cureus.73947. eCollection 2024 Nov.
3
Racial and Socioeconomic Health Disparities in Peripheral Artery Disease.
外周动脉疾病中的种族和社会经济健康差异。
J Am Heart Assoc. 2024 Nov 5;13(21):e031446. doi: 10.1161/JAHA.123.031446. Epub 2024 Nov 4.
4
Competing risk analysis to estimate amputation incidence and risk in lower-extremity peripheral artery disease.竞争风险分析估计下肢外周动脉疾病的截肢发病率和风险。
Vasc Med. 2024 Oct;29(5):496-506. doi: 10.1177/1358863X241268727. Epub 2024 Sep 1.
5
Contraindications to use of neuraxial anesthesia for lower limb revascularization surgery in adults: a cross-sectional study.成人下肢血运重建手术中应用椎管内麻醉的禁忌证:一项横断面研究。
Can J Anaesth. 2024 Jun;71(6):808-817. doi: 10.1007/s12630-023-02546-8. Epub 2023 Jul 27.
6
Evaluation of the ICD-10 system in coding revascularisation procedures in patients with peripheral arterial disease in England: A retrospective cohort study using national administrative and clinical databases.英格兰外周动脉疾病患者血运重建手术编码中ICD-10系统的评估:一项使用国家行政和临床数据库的回顾性队列研究。
EClinicalMedicine. 2022 Nov 12;55:101738. doi: 10.1016/j.eclinm.2022.101738. eCollection 2023 Jan.
7
Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT Global Study.紫杉醇涂层球囊治疗股腘动脉外周动脉疾病:IN.PACT 全球研究的最终五年结果。
EuroIntervention. 2022 Dec 2;18(11):e940-e948. doi: 10.4244/EIJ-D-21-01098.
8
Younger patients with chronic limb threatening ischemia face more frequent amputations.年轻的慢性肢体威胁性缺血患者面临更频繁的截肢。
Am Heart J. 2021 Dec;242:6-14. doi: 10.1016/j.ahj.2021.08.002. Epub 2021 Aug 8.
9
Algorithm of Medical-Surgical Treatment in the Peripheral Arterial Disease of the Diabetic Patient.糖尿病患者外周动脉疾病的外科治疗算法
Maedica (Bucur). 2020 Sep;15(3):310-317. doi: 10.26574/maedica.2020.15.3.310.
10
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.紫杉醇涂层 Zilver PTX 药物洗脱支架治疗与未涂层器械相比,不会增加长期全因死亡率。
Cardiovasc Intervent Radiol. 2020 Jan;43(1):8-19. doi: 10.1007/s00270-019-02324-4. Epub 2019 Sep 9.